NCT05804006

Brief Summary

Although High-intensity interval training (HIIT) exercise has emerged in recent years as a powerful time-efficient alternative to moderate-intensity continuous cardiovascular exercise training (MICT) to enhance neuroplasticity, motor, and cognitive functions, its feasibility remains to be determined early after stroke. Our study aims to investigate the feasibility of the HIIT program and its effects on functional abilities, cognitive function, and quality of life in early post-stroke.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 15, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 7, 2023

Completed
Last Updated

April 7, 2023

Status Verified

April 1, 2023

Enrollment Period

4 months

First QC Date

February 15, 2023

Last Update Submit

April 6, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility aspects

    The feasibility aspects, include recruitment rates (eligible population / consented population x 100), program adherence (attended sessions / total number of sessions x 100), and the safety (percentage of participants who will experience adverse events)

    Up to 6 weeks

  • The change in the credibility of the treatment and the expectations of the participants

    The treatment credibility and participant expectancy for improvement will be assessed with the Credibility and Expectancy Questionnaire (CEQ). The CEQ includes six items assessing a cognitively based credibility factor and an affectively based expectancy factor

    Week 1 and Week 6

Secondary Outcomes (7)

  • Berg Balance Scale

    Week 1 and Week 6

  • 5-Repetition Sit-To-Stand test

    Week 1 and Week 6

  • modified Rankin Scale

    Week 1 and Week 6

  • 6-min walk test

    Week 1 and Week 6

  • 10 m walk test

    Week 1 and Week 6

  • +2 more secondary outcomes

Study Arms (1)

HIIT-REC

EXPERIMENTAL

High-intensity interval training program on a recumbent cycle SOLE R92 (HIIT-REC)

Other: Conventional physiotherapy followed by HIIT-REC program

Interventions

The experimental protocol will be preceded by 30 minutes of conventional physiotherapy followed by 15 min the rest period; then the HIIT-REC procedure will start at 4-min at 30% of the peak workload interspersed with 1-min at 70% of the peak workload at 50 rpm for weeks 1-2 and increased by approximately 5 minutes every two weeks as tolerated to reach 30 minutes from week 5 (4 to 6 repetitions). The training intensity will progress similarly by 5% peak workload two weeks as tolerated to reach 4-min at 40% peak workload interspersed with 1-min 80% peak workload from week-5

HIIT-REC

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • first episode from an ischemic or hemorrhagic stroke confirmed by CT scan;
  • muscular weakness of the leg on the hemiplegic side defined as NIHSS-Item 6 score between 1 and 3;
  • Ashworth score of 0 or 1, indicating no spasticity or slight spasticity over the affected lower limb, respectively
  • able to walk at least 5 meters independently with or without assistive devices and understand spoken instructions;
  • living in Parakou or the surrounding area and wishing to undergo the program at the hospital.

You may not qualify if:

  • Participants:
  • unable to perform a graded exercise test, i.e., unable to maintain the designated pedaling rate;
  • cardiovascular diseases (uncontrolled arrhythmias, decompensated heart failure or recent myocardial injury, arteriopathy);
  • primary orthopedic conditions (fractures, active rheumatoid arthritis);
  • other neurological diseases such as (Parkinson's disease and Alzheimer's disease).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Rehabilitation Sciences

Diepenbeek, 3590, Belgium

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Oyene R Kossi, PhD

    University of Parakou

    STUDY DIRECTOR
  • Thierry R Adoukonou, MD, PhD

    University of Parakou

    STUDY DIRECTOR
  • Peter R Feys, PhD

    Hasselt University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elogni R Amanzonwé, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Conventional physiotherapy followed by High-Intensity Interval training on the semi-recumbent bike
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor of Rehabilitation/Exercise Physiology in Cardiometabolic Diseases

Study Record Dates

First Submitted

February 15, 2023

First Posted

April 7, 2023

Study Start

December 1, 2022

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

April 7, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Data will be available to researchers upon request to the first author (ERA)

Locations